Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
نویسندگان
چکیده
منابع مشابه
Chemokines in chronic progressive neurological multiple sclerosis
Chemokines are 8 ± 12 kd chemoattractant cytokines characterized by a four cysteine motif (Luster, 1998; Ransohoff et al, 1996; Schall, 1994; Taub, 1996). The presence or absence of an intervening amino acid(s) (X) between the N terminal cysteines de®nes the CXC/CX3C and CC families, respectively. A third family, C chemokines, lacks an N terminal cysteine but is otherwise homologous. It was ori...
متن کاملExploring recombinant human erythropoietin in chronic progressive multiple sclerosis.
The neurodegenerative aspects of chronic progressive multiple sclerosis (MS) have received increasing attention in recent years, since anti-inflammatory and immunosuppressive treatment strategies have largely failed. However, successful neuroprotection and/or neuroregeneration in MS have not been demonstrated yet. Encouraged by the multifaceted neuroprotective effects of recombinant human eryth...
متن کاملBrain Viscoelasticity Alteration in Chronic-Progressive Multiple Sclerosis
INTRODUCTION Viscoelastic properties indicate structural alterations in biological tissues at multiple scales with high sensitivity. Magnetic Resonance Elastography (MRE) is a novel technique that directly visualizes and quantitatively measures biomechanical tissue properties in vivo. MRE recently revealed that early relapsing-remitting multiple sclerosis (MS) is associated with a global decrea...
متن کاملIntense immunosuppression and autologous hematopoietic stem cell transplantation for multiple sclerosis.
press. 32. Bumm T, Mueller C, Leiblein S. Restoration of polyclonal hematopoiesis in most CML patients in complete cytogenetic remission to imatinib but rapid emergence of clonal cytogenetic abnormalities in Ph-negative cells in a subset of patients. Blood 2002;100: 613a[abstract]. 33. Druker BJ, Sawyers CL, Capdeville R. Chronic myelogenous leukemia. Hematology (Am Soc Hematol Educ Program) 20...
متن کاملPrimary-progressive multiple sclerosis.
About 10-15% of patients with multiple sclerosis (MS) present with gradually increasing neurological disability, a disorder known as primary-progressive multiple sclerosis (PPMS). Compared with relapse-onset multiple sclerosis, people with PPMS are older at onset and a higher proportion are men. Inflammatory white-matter lesions are less evident but diffuse axonal loss and microglial activation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 1991
ISSN: 0022-3050
DOI: 10.1136/jnnp.54.12.1055